Search Results 511-520 of 16893 for Celecoxib

  1. Neurology - Clinical trials - Mayo Clinic

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  2. A Study to Evaluate APG2575 Combined with Novel Therapeutic Regimens To Treat Subjects with Relapsed or Refractory Multiple Myeloma and Immunoglobulin Light Chain Amyloidosis - Mayo Clinic

    About this study. The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated ...

  3. Ganciclovir (ophthalmic route) - Side effects & dosage - Mayo Clinic

    Ganciclovir ophthalmic (eye) gel is used to treat acute herpetic keratitis (dendritic ulcers). Herpetic keratitis is an eye infection (swelling of the front ...

  4. Cholesterol medications: Consider the options - Mayo Clinic

    Combination cholesterol absorption inhibitor and statin. Ezetimibe-simvastatin (Vytorin), Decreases LDL and triglycerides; increases HDL, Stomach pain, fatigue, ...

  5. Sorafenib (oral route) - Side effects & dosage - Mayo Clinic

    Sorafenib is used to treat late-stage kidney cancer (advanced renal cell carcinoma), liver cancer (hepatocellular carcinoma) that cannot be treated by surgery, ...

  6. Oncology (Medical) - Clinical trials

    This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...

  7. Clinical trials - Oncology (Medical)

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  8. Study Comparing CB-839 with Cabozantinib vs. Cabozantinib with Placebo in Patients with Metastatic Renal Cell Carcinoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Study To Evaluate The Safety, Tolerability, And Effects On Blood And Urine Markers Of Single Ascending Dose Of GSK4771261 In Healthy Participants And Participants With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    This is a study where a new drug, called GSK4771261 is being tested. Neither the study doctors, study staff or participants will be aware of what treatment is ...

  10. Sorafenib for Hepatopulmonary Syndrome - Mayo Clinic

    About this study. The main purpose of this clinical trial is to determine the safety and effects of the study drug, sorafenib, in adults diagnosed with ...